Today, the Biden-Harris administration unveiled the final negotiated prices for the Inflation Reduction Act’s historic Medicare negotiation program. In 2026, seniors and other Medicare Part D enrollees are expected to save $1.5 billion in out-of-pocket costs for prescription drugs, with Medicare itself saving $6 billion when compared to 2023 totals
Following the U.S. Labor Department’s Consumer Price Index (CPI), a new report from government watchdog Accountable.US revealed today that the producers of the first 10 medications under the Biden-Harris administration’s historic Medicare negotiation program brought in over $93 billion in combined profits and invested heavily on stock buybacks and
With the second anniversary of the Biden-Harris Inflation Reduction Act approaching and its cost-lowering Medicare drug price negotiations nearing the finish line, today Senator Amy Klobuchar (D-MN) joined Patients For Affordable Drugs for a briefing hosted by government watchdog Accountable.US to discuss lowering drug costs for everyday Americans
This week, the Biden-Harris administration will announce final negotiated prices Medicare negotiated under the Inflation Reduction Act. This is the first time in history Medicare has been able to use its authority to lower prescription drug costs for seniors. And the big drug companies do not like it.
Eli Lilly announced nearly $3 billion in Q2 2024 earnings today, a 68% increase from the previous year. Eli Lilly’s diabetes medication, Jardiance—which it co-manufactures with Boehringer Ingelheim—is one of the first 10 medications subject to the Biden-Harris administration’s historic Medicare negotiation program. The drug saw an 11% increase in Q
Just a week after losing its case to block the Biden-Harris administration’s historic Medicare negotiation program, Novo Nordisk announced $1.86 billion in Q2 2024 earnings—a total bolstered by a 41% increase in US insulin sales. The pharmaceutical giant’s insulin medication, Fiasp/NovoLog, is one of the first 10 medications subject to the Biden-Ha
In Forthcoming Book Roberts Doubles Down On Opposition To Birth Control, IVF
New analysis from government watchdog Accountable.US revealed today major food chains Starbucks and Kraft Heinz increased spending on shareholder dividends and stock buybacks while raising prices on millions of American customers. These brands saw overall earnings decline as customers continue to push back against excessive price hikes.
Despite Claims of Securing Rights, Research Shows Project 2025 Seeks to Exert More Control Over Americans’ Lives by Limiting Freedoms.
Issuing a major win for seniors and patients struggling to afford life-saving medications, New Jersey District Court Judge Zahid Quraishi rejected Novo Nordisk’s challenge to the Inflation Reduction Act yesterday, ruling against the pharmaceutical giant’s attempt to ban Medicare from negotiating lower drug prices with manufacturers.
Get the latest news on how we’re holding big business, government officials, and special interests accountable, and what you can do to get involved.
By submitting your cell phone number you are agreeing to receive periodic text messages from this organization. Message and data rates may apply. Text HELP for more information. Text STOP to stop receiving messages.
